3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
5
Thoracic
1
Sarcoma
1
Gastrointestinal
1
Dermatologic
1
Conditions
Gastrointestinal Stromal Tumors
17
Sarcoma
6
Sarcoma, Ewing
5
Osteosarcoma
5
Neoplasm Metastasis
4
Rhabdomyosarcoma
3
Colorectal Neoplasms
3
Mesothelioma, Malignant
2
Hemangiosarcoma
2
Chondrosarcoma
2
Bone Neoplasms
2
Wilms Tumor
1
Turcot syndrome
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Thymoma
1
Tertiary Lymphoid Structures
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Piebaldism
1
Patient Compliance
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neuroblastoma
1
Neoplasms
1
Melanoma
1
Liposarcoma
1
Leiomyosarcoma
1
Histiocytoma, Malignant Fibrous
1
Interventions
Filgrastim
14
Cyclophosphamide
13
Carboplatin
12
Paclitaxel
8
Ifosfamide
8
Doxorubicin
8
pembrolizumab
7
Peripheral Blood Stem Cell Transplantation
6
Gemcitabine
6
fludarabine
5
Temozolomide
5
Specimen Handling
5
Radiotherapy
5
Cisplatin
5
Magnetic Resonance Spectroscopy
4
Etoposide
4
Docetaxel
4
Amifostine
4
aldesleukin
3
Trastuzumab
3
Taxes
3
Psychiatric Rehabilitation
3
Melphalan
3
Fulvestrant
3
Bevacizumab
3
sodium thiosulfate
2
pazopanib
2
pamiparib
2
palbociclib
2
etoposide phosphate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ovarian Neoplasms
×
regorafenib
×
Sarcoma
×
Clear all
NCT02307500
2022-09-10
RESOUND
Istituto Clinico Humanitas
Phase 2
Completed
82 enrolled